Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
NMBS-2 by Nimbus Therapeutics for Colon Cancer: Likelihood of Approval
NMBS-2 is under clinical development by Nimbus Therapeutics and currently in Phase II for Colon Cancer. According to GlobalData, Phase...
NMBS-2 by Nimbus Therapeutics for Pancreatic Cancer: Likelihood of Approval
NMBS-2 is under clinical development by Nimbus Therapeutics and currently in Phase II for Pancreatic Cancer. According to GlobalData, Phase...
NMBS-2 by Nimbus Therapeutics for Endometrial Cancer: Likelihood of Approval
NMBS-2 is under clinical development by Nimbus Therapeutics and currently in Phase II for Endometrial Cancer. According to GlobalData, Phase...
NMBS-2 by Nimbus Therapeutics for Renal Cell Carcinoma: Likelihood of Approval
NMBS-2 is under clinical development by Nimbus Therapeutics and currently in Phase II for Renal Cell Carcinoma. According to GlobalData,...
NMBS-2 by Nimbus Therapeutics for Non-Small Cell Lung Cancer: Likelihood of Approval
NMBS-2 is under clinical development by Nimbus Therapeutics and currently in Phase II for Non-Small Cell Lung Cancer. According to...